胰腺腺癌细胞上的NPC1L1功能作为对抗瘤活动的双边检查点
Ruiyang Zi1, Kaicheng Shen2, Pengfei Zheng3
1Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
Innovation (Cambridge (Mass.))
|March 18, 2025
概括
胰腺腺癌细胞利用NPC1L1通过劫持胆固醇来抑制抗瘤免疫力. 用ezetimibe抑制NPC1L1可以恢复免疫反应,并与胰腺癌治疗中的PD-1阻断协同作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 胰腺腺癌 (PAAD) 是一种具有免疫抑制性瘤微环境的致命癌症,导致免疫治疗反应差.
- 重编程胆固醇代谢对于PAAD细胞生长和生存至关重要.
- 通过PAAD细胞操纵胆固醇以促进生长和逃避免疫监测的机制尚未完全理解.
研究的目的:
- 阐明PAAD细胞如何重编程胆固醇代谢以支持瘤生长并创造免疫抑制的微环境.
- 研究NPC1L1在PAAD免疫逃避策略中的作用.
- 评估NPC1L1抑制作为一种治疗策略,以增强PAAD中的抗瘤免疫力.
主要方法:
- 在PAAD中分析NPC1L1表达.
- 研究NPC1L1对T细胞受体 (TCR) 激活和CD8+T细胞中的胆固醇水平的影响.
- 在PAAD小鼠模型中使用ezetimibe (NPC1L1抑制剂) 结合PD-1阻断的体内研究.
主要成果:
- PAAD细胞异位过度表达NPC1L1,一种胆固醇转运体.
- NPC1L1起到检查点的作用,抑制CD8+ T细胞TCR激活,并降低其细胞内胆固醇.
- 埃泽胺治疗防止了CD8+T细胞的胆固醇剥夺,并增强了抗瘤免疫力,与PD-1阻断产生协同作用.
结论:
- 在PAAD细胞中NPC1L1过度表达是免疫逃避和瘤生长的关键机制.
- 用ezetimibe针对NPC1L1可以恢复PAAD微环境中的抗瘤免疫力.
- 抑制NPC1L1代表了一种有前途的治疗策略,以提高胰腺癌免疫疗法的疗效.
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:31The Intrinsic Apoptotic Pathway
5.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K
02:39Positive Regulator Molecules
5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
01:23Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K